Ratings by H.C. Wainwright (Patrick R. Trucchio)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/9/2026 | Helus Pharma | HELP | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2026 | Faeth Therapeutics | FTH | New Coverage | Buy (N/A) |
17.82 (36.16) |
102.92% | Details | |
| 6/16/2026 | Pharvaris B.V. | PHVS | Maintain | Buy (Buy) |
|
Details | ||
| 5/26/2026 | Sangamo BioSciences | SGMO | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2026 | Voyager Therapeutics | VYGR | Maintain | Buy (Buy) |
|
Details | ||
| 5/19/2026 | GH Research PLC | GHRS | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2026 | Definium Therapeutics Inc | DFTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/18/2026 | Voyager Therapeutics | VYGR | Maintain | Buy (Buy) |
|
Details | ||
| 2/5/2026 | Voyager Therapeutics | VYGR | Maintain | Buy (Buy) |
|
Details | ||
| 1/22/2026 | Pharvaris B.V. | PHVS | Maintain | Buy (Buy) |
|
Details | ||
| 11/13/2025 | Voyager Therapeutics | VYGR | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2025 | GH Research PLC | GHRS | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2025 | Pharvaris B.V. | PHVS | Maintain | Buy (Buy) |
|
Details | ||
| 9/5/2025 | Sangamo BioSciences | SGMO | Maintain | Buy (Buy) |
|
Details | ||
| 7/25/2025 | GH Research PLC | GHRS | Maintain | Buy (Buy) |
|
Details | ||
| 6/25/2025 | Sangamo BioSciences | SGMO | Maintain | Buy (Buy) |
|
Details | ||
| 5/29/2025 | Sangamo BioSciences | SGMO | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2025 | Sangamo BioSciences | SGMO | Maintain | Buy (Buy) |
|
Details | ||
| 3/13/2025 | Voyager Therapeutics | VYGR | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2025 | GH Research PLC | GHRS | Maintain | Buy (Buy) |
|
Details | ||
| 2/4/2025 | GH Research PLC | GHRS | Maintain | Buy (Buy) |
|
Details | ||
| 1/27/2025 | Voyager Therapeutics | VYGR | Maintain | Buy (Buy) |
|
Details | ||
| 1/27/2025 | GH Research PLC | GHRS | Maintain | Buy (Buy) |
|
Details | ||
| 1/2/2025 | Sangamo BioSciences | SGMO | Maintain | Buy (Buy) |
|
Details | ||
| 11/20/2024 | GH Research PLC | GHRS | Maintain | Buy (Buy) |
|
Details | ||
| 11/5/2024 | Sangamo BioSciences | SGMO | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2024 | GH Research PLC | GHRS | Maintain | Buy (Buy) |
|
Details | ||
| 8/20/2024 | Voyager Therapeutics | VYGR | Maintain | Buy (Buy) |
|
Details | ||
| 3/19/2024 | Sangamo BioSciences | SGMO | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2024 | Voyager Therapeutics | VYGR | New Coverage | Buy (N/A) |
9.09 (3.44) |
-62.16% | Details | |
| 11/6/2023 | Sangamo BioSciences | SGMO | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2023 | Sangamo BioSciences | SGMO | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2023 | Sangamo BioSciences | SGMO | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2022 | GH Research PLC | GHRS | New Coverage | Buy (N/A) |
13.34 (26.51) |
98.73% | Details |
